Seasonal Allergic Rhinitis Market Is Driven By Growing Environmental Pollution Levels

By Author: colin
Total Articles: 197
Comment this article

The seasonal allergic rhinitis market consists of drugs and products used for treating seasonal allergic rhinitis commonly known as hay fever. It is an allergic reaction to certain substances in the air like pollen, mold spores, smoke, dust, and animal dander. Common symptoms include sneezing, nasal itching, congestion, and runny nose. Oral antihistamines and nasal corticosteroids are widely used for treating symptoms and preventing allergen-induced inflammation. The demand for seasonal allergy therapeutics is rising owing to increasing environmental pollution levels, changing climate, and growing pollen counts.
The Seasonal Allergic Rhinitis Market is estimated to be valued at US$ 10.8 Bn in 2024 and is expected to exhibit a CAGR of 2.9% over the forecast period 2024-2031.
Key players operating in the seasonal allergic rhinitis market are Regeneron Pharmaceuticals, Revolo Biotherapeutics, Allergy Therapeutics, Emergo Therapeutics, ALKAbello. Key players are focusing on developing novel biologic therapies to address unmet needs. Regeneron Pharmaceuticals' Dupixent is a prime example of a biologic allergy therapeutic ...
... with a strong clinical profile.
The growing demand for efficacious treatments can be attributed to rising pollution levels that enhance theallergenicity of pollen and exacerbate symptoms in sensitized individuals. Emerging economies experiencing growth in urbanization and industrial activities parallelly witness increased air particulate matter without proper emission controls. This skyrockets pollen counts and exposes a massive population to allergens.
Geographically, North America dominates the seasonal allergic rhinitis market due to a higher disease prevalence, developed healthcare infrastructure, and regulatory approvals for advanced therapies. However, Asia Pacific is set to accelerate with China and India emerging as high potential markets. This is supported by economic expansions, growing medical tourism, and increased access to insurance schemes.
The key drivers for the seasonal allergic rhinitis market involve a rising global pollen count associated with climate change. Warming temperatures extend the allergenic plant growth season and alter pollen production patterns. According to researchers, climate change could increase pollen seasons by up to 20 days and pollen levels by over 20% in recent decades. This amplifies seasonal allergic triggers and drives the need for effective therapies.
The current geopolitical tensions and conflicts are negatively impacting the growth of the Seasonal Allergic Rhinitis Market. Due to global trade restrictions and supply chain disruptions caused by ongoing Russia-Ukraine war, prices of various seasonal allergic rhinitis treatment drugs have increased significantly. Accessibility of these drugs has reduced in many regions worldwide. This will decrease treatment rates for seasonal allergic rhinitis patients in short term.
Geopolitical conflicts also contribute to increased stress levels and air pollution globally. As stress and air pollution are known triggers for seasonal allergy symptoms, prevalence of seasonal allergic rhinitis cases is expected to rise in coming years. This will drive demand for treatment drugs in long run and help market recover losses from short term supply issues. However, ongoing geopolitical uncertainties continue posing challenges.
Market players need to diversify and expand facilities, source raw materials from multiple regions to minimize impact of trade restrictions. Developing niche products with localized treatments and strengthening online sales channels can help address supply issues. Partnerships with local pharma companies in emerging markets will aid market access. Focus on natural alternatives and homeopathic drugs may also see increased uptake if conventional drugs remain in short supply due to geo-political tensions.
In terms of value, North America accounts for the largest share in seasonal allergic rhinitis market currently due to developed healthcare infrastructure and high acceptance of new treatment options. However, Asia Pacific region is poised to witness fastest growth during forecast period. Rising environmental pollution, growing patient awareness and improving access to healthcare in developing Asian countries are driving higher treatment rates. China, India are emerging as lucrative markets with presence of huge population base already impacted or at risk of developing seasonal allergic rhinitis.

Get more insights on this topic:https://heyjinni.com/read-blog/143422

Author Bio:
Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights. (LinkedIn: www.linkedin.com/in/alice-mutum-3b247b137 )
What Are The Key Data Covered In This Seasonal Allergic Rhinitis Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Seasonal Allergic Rhinitis Market's growth between 2024 and 2031.
:- Accurate calculation of the size of the Seasonal Allergic Rhinitis Market and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Seasonal Allergic Rhinitis Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market's competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Seasonal Allergic Rhinitis Market vendors
FAQ’s
Q.1 What are the main factors influencing the Seasonal Allergic Rhinitis Market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Seasonal Allergic Rhinitis Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Seasonal Allergic Rhinitis Market’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it